— Know what they know.
Not Investment Advice
Also trades as: 0HKD.L (LSE) · $vol 0M

AXGN NASDAQ

AxoGen, Inc.
1W: +0.9% 1M: +11.7% 3M: +17.0% YTD: +33.3% 1Y: +257.0% 3Y: +348.5% 5Y: +92.4%
$40.90
-0.41 (-0.99%)
 
Weekly Expected Move ±6.2%
$36 $38 $41 $44 $46
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 64 · $2.2B mcap · 52M float · 2.06% daily turnover · Short 47% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -6.3%  ·  5Y Avg: -14.9%
Cost Advantage ★
69
Intangibles
52
Switching Cost
41
Network Effect
52
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AXGN shows a Weak competitive edge (50.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -6.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$48
Low
$49
Avg Target
$50
High
Based on 3 analysts since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$46.80
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-29 Raymond James $41 $48 +7 +14.9% $41.79
2026-04-29 Canaccord Genuity Caitlin Roberts $45 $50 +5 +19.1% $41.99
2026-04-29 H.C. Wainwright $39 $50 +11 +19.1% $41.99
2026-04-24 Canaccord Genuity $37 $45 +8 +20.3% $37.41
2026-02-23 Raymond James Jayson Bedford $36 $41 +5 +17.1% $35.00
2026-02-19 Wells Fargo Initiated $40 +13.5% $35.25
2025-12-05 H.C. Wainwright $26 $39 +13 +15.7% $33.70
2025-12-05 Canaccord Genuity $27 $37 +10 +12.6% $32.85
2025-12-04 Raymond James Jayson Bedford Initiated $36 +8.5% $33.19
2025-12-04 Lake Street Frank Takkinen Initiated $40 +24.6% $32.10
2025-12-04 Jefferies Initiated $36 +27.1% $28.33
2025-12-01 Mizuho Securities Initiated $40 +39.6% $28.65
2025-10-30 H.C. Wainwright $25 $26 +1 +13.7% $22.86
2025-10-30 Canaccord Genuity Initiated $27 +21.3% $22.25
2025-10-30 JMP Securities Initiated $34 +52.8% $22.25
2025-09-30 H.C. Wainwright Yi Chen Initiated $25 +44.8% $17.26

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AXGN receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-04 D+ C-
2026-04-01 C- D+
2026-02-24 D+ C-
2026-01-13 C- D+
2026-01-03 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

44 Grade D
Profitability
20
Balance Sheet
75
Earnings Quality
32
Growth
50
Value
27
Momentum
48
Safety
100
Cash Flow
49
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AXGN scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.69
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-3.33
Unlikely Manipulator
Ohlson O-Score
-6.58
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A-
Score: 68.0/100
Trend: Improving
Earnings Quality
OCF/NI: -0.49x
Accruals: -22.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AXGN scores 10.69, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AXGN scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AXGN's score of -3.33 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AXGN's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AXGN receives an estimated rating of A- (score: 68.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-67.09x
PEG
0.26x
P/S
9.13x
P/B
8.62x
P/FCF
191.34x
P/OCF
109.88x
EV/EBITDA
297.32x
EV/Revenue
7.11x
EV/EBIT
-2129.46x
EV/FCF
189.51x
Earnings Yield
-1.84%
FCF Yield
0.52%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AXGN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
39.564
EBT / EBIT
×
EBIT Margin
-0.003
EBIT / Rev
×
Asset Turnover
1.119
Rev / Assets
×
Equity Multiplier
1.828
Assets / Equity
=
ROE
-27.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AXGN's ROE of -27.0% is driven by Asset Turnover (1.119), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$40.90
Median 1Y
$36.60
5th Pctile
$12.93
95th Pctile
$104.90
Ann. Volatility
64.5%
Analyst Target
$46.80
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael Dale
CEO and President
$775,865 $7,342,895 $9,047,454
Marc Began GC
ecutive Vice President and GC
$439,051 $2,290,750 $3,063,430
Jens Kemp Marketing
keting Officer
$395,205 $1,582,700 $2,279,206
Erick DeVinney Innovation
vation Officer
$414,607 $1,582,700 $2,261,741
Lindsey Hartley
CFO
$395,065 $1,302,420 $1,935,226
Nir Naor
Former CFO
$228,186 $— $271,544

CEO Pay Ratio

40:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,047,454
Avg Employee Cost (SGA/emp): $228,805
Employees: 622

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
622
+37.6% YoY
Revenue / Employee
$362,071
Rev: $225,208,000
Profit / Employee
$-25,246
NI: $-15,703,000
SGA / Employee
$228,805
Avg labor cost proxy
R&D / Employee
$52,870
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -17.3% -21.7% -22.9% -27.0% -26.8% -24.5% -27.1% -23.0% -22.0% -21.8% -22.1% -21.6% -16.8% -14.5% -10.0% -7.2% -4.7% -2.1% -13.5% -27.0% -27.03%
ROA -12.4% -15.6% -13.2% -15.5% -15.5% -14.1% -14.4% -12.2% -11.6% -11.5% -11.1% -10.8% -8.4% -7.3% -5.0% -3.6% -2.3% -1.0% -7.4% -14.8% -14.79%
ROIC -21.2% -27.2% -20.9% -25.1% -25.8% -24.3% -19.6% -17.0% -16.3% -15.8% -12.7% -11.0% -7.2% -5.0% -1.9% -0.2% 1.0% 2.2% -5.5% -6.3% -6.33%
ROCE -11.2% -14.4% -13.9% -16.6% -16.7% -15.4% -16.5% -14.1% -13.5% -13.0% -11.3% -9.7% -5.6% -3.6% -1.0% 0.6% 1.9% 8.2% 0.2% -0.4% -0.40%
Gross Margin 78.9% 83.2% 82.8% 82.1% 81.8% 83.3% 83.0% 81.7% 77.7% 76.8% 78.7% 78.8% 73.8% 74.9% 76.1% 71.9% 74.2% 76.6% 74.1% 75.2% 75.16%
Operating Margin -21.3% -21.4% -17.0% -36.5% -23.0% -13.1% -15.5% -20.0% -18.1% -9.8% -7.4% -11.0% -0.9% -0.6% 4.1% -3.4% 3.0% 3.2% -16.3% -4.6% -4.61%
Net Margin -23.5% -22.9% -16.8% -37.0% -22.5% -11.7% -15.0% -19.3% -17.5% -9.9% -9.1% -16.0% -4.0% -3.8% 0.9% -7.9% 1.0% 1.2% -22.0% -31.9% -31.87%
EBITDA Margin -18.4% -17.8% -13.4% -32.0% -18.2% -8.1% -11.7% -15.9% -14.3% -4.5% -0.5% -5.8% 4.9% 4.1% 8.4% 0.6% 7.7% 21.1% -14.2% -4.6% -4.61%
FCF Margin -20.2% -25.9% -33.5% -35.1% -35.4% -30.2% -26.1% -22.0% -17.7% -15.4% -12.7% -13.4% -8.6% -5.5% 0.0% 0.1% 2.1% 1.3% -1.5% 3.8% 3.75%
OCF Margin -4.6% -7.1% -10.5% -10.7% -14.5% -14.1% -11.6% -8.6% -4.4% -2.7% -3.6% -6.4% -3.9% -2.4% 2.4% 1.9% 3.5% 3.0% 0.4% 6.5% 6.53%
ROE 3Y Avg snapshot only -17.85%
ROE 5Y Avg snapshot only -21.22%
ROA 3Y Avg snapshot only -9.50%
ROIC 3Y Avg snapshot only -8.37%
ROIC Economic snapshot only -4.97%
Cash ROA snapshot only 7.02%
Cash ROIC snapshot only 13.82%
CROIC snapshot only 7.94%
NOPAT Margin snapshot only -2.99%
Pretax Margin snapshot only -13.21%
R&D / Revenue snapshot only 14.41%
SGA / Revenue snapshot only 64.39%
SBC / Revenue snapshot only 14.30%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -40.27 -23.65 -14.40 -10.44 -10.87 -17.46 -14.59 -16.39 -16.68 -9.26 -13.54 -16.40 -19.14 -43.00 -79.50 -116.75 -106.12 -390.53 -97.82 -54.34 -67.087
P/S Ratio 6.80 5.11 3.05 2.61 2.68 3.76 3.05 2.79 2.65 1.41 1.85 2.13 1.82 3.40 4.23 4.30 2.43 3.81 6.82 7.18 9.135
P/B Ratio 7.21 5.32 3.45 2.95 3.06 4.47 4.18 3.98 3.87 2.13 3.07 3.65 3.31 6.43 7.62 8.05 4.76 7.88 11.92 13.27 8.619
P/FCF -33.63 -19.72 -9.10 -7.42 -7.58 -12.42 -11.68 -12.66 -14.95 -9.20 -14.61 -15.86 -21.18 -62.15 72010.11 4569.80 116.21 287.05 -468.58 191.34 191.338
P/OCF 174.67 230.89 68.85 125.82 1891.62 109.88 109.876
EV/EBITDA -53.69 -28.87 -17.80 -12.17 -12.59 -20.77 -18.81 -21.78 -22.15 -13.45 -24.93 -39.00 -165.85 381.05 136.14 99.18 48.90 39.75 172.22 297.32 297.317
EV/Revenue 6.42 4.72 2.92 2.48 2.55 3.63 3.18 2.92 2.77 1.54 2.09 2.36 2.04 3.61 4.42 4.48 2.61 3.98 6.75 7.11 7.110
EV/EBIT -41.82 -23.59 -14.51 -10.33 -10.66 -17.24 -15.59 -17.38 -17.64 -10.51 -17.60 -24.00 -37.91 -107.84 -470.33 902.15 162.68 60.40 3354.72 -2129.46 -2129.460
EV/FCF -31.76 -18.23 -8.71 -7.05 -7.21 -12.01 -12.20 -13.24 -15.67 -9.99 -16.52 -17.60 -23.74 -66.02 75210.47 4762.17 124.48 299.39 -463.60 189.51 189.513
Earnings Yield -2.5% -4.2% -6.9% -9.6% -9.2% -5.7% -6.9% -6.1% -6.0% -10.8% -7.4% -6.1% -5.2% -2.3% -1.3% -0.9% -0.9% -0.3% -1.0% -1.8% -1.84%
FCF Yield -3.0% -5.1% -11.0% -13.5% -13.2% -8.1% -8.6% -7.9% -6.7% -10.9% -6.8% -6.3% -4.7% -1.6% 0.0% 0.0% 0.9% 0.3% -0.2% 0.5% 0.52%
PEG Ratio snapshot only 0.256
Price/Tangible Book snapshot only 13.999
EV/OCF snapshot only 108.827
EV/Gross Profit snapshot only 9.478
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.36 6.36 5.23 5.23 5.23 5.23 4.13 4.13 4.13 4.13 2.89 2.89 2.89 2.89 3.24 3.24 3.24 3.24 5.11 5.11 5.112
Quick Ratio 5.81 5.81 4.54 4.54 4.54 4.54 3.33 3.33 3.33 3.33 2.14 2.14 2.14 2.14 2.16 2.16 2.16 2.16 3.31 3.31 3.313
Debt/Equity 0.44 0.44 0.60 0.60 0.60 0.60 0.67 0.67 0.67 0.67 0.72 0.72 0.72 0.72 0.66 0.66 0.66 0.66 0.15 0.15 0.149
Net Debt/Equity -0.40 -0.40 -0.15 -0.15 -0.15 -0.15 0.18 0.18 0.18 0.18 0.40 0.40 0.40 0.40 0.34 0.34 0.34 0.34 -0.13 -0.13 -0.127
Debt/Assets 0.27 0.27 0.32 0.32 0.32 0.32 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.34 0.34 0.34 0.34 0.09 0.09 0.087
Debt/EBITDA -3.50 -2.60 -3.23 -2.60 -2.59 -2.88 -2.88 -3.49 -3.64 -3.88 -5.20 -6.98 -32.39 40.40 11.30 7.82 6.34 3.20 2.18 3.38 3.379
Net Debt/EBITDA 3.16 2.35 0.80 0.64 0.64 0.71 -0.80 -0.96 -1.01 -1.07 -2.87 -3.85 -17.89 22.31 5.79 4.01 3.25 1.64 -1.85 -2.86 -2.864
Interest Coverage -10.02 -12.71 -17.97 -22.86 -30.09 -42.51 -42.60 -74.30 -103.30 -22.45 -6.66 -3.14 -1.30 -0.73 -0.21 0.12 0.41 0.87 0.03 -0.05 -0.054
Equity Multiplier 1.64 1.64 1.85 1.85 1.85 1.85 1.93 1.93 1.93 1.93 2.06 2.06 2.06 2.06 1.96 1.96 1.96 1.96 1.72 1.72 1.721
Cash Ratio snapshot only 1.509
Debt Service Coverage snapshot only 0.390
Cash to Debt snapshot only 1.847
FCF to Debt snapshot only 0.464
Defensive Interval snapshot only 120.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.73 0.72 0.62 0.62 0.63 0.65 0.69 0.72 0.73 0.75 0.81 0.83 0.88 0.92 0.94 0.97 1.01 1.07 1.06 1.12 1.119
Inventory Turnover 1.78 1.74 1.57 1.60 1.54 1.60 1.36 1.42 1.55 1.74 1.62 1.72 1.91 2.04 1.61 1.79 1.86 1.93 1.53 1.57 1.575
Receivables Turnover 7.55 7.43 7.12 7.12 7.17 7.49 6.87 7.15 7.33 7.55 6.72 6.92 7.33 7.64 7.61 7.90 8.25 8.72 8.96 9.47 9.472
Payables Turnover 3.64 3.57 4.36 4.43 4.28 4.46 3.24 3.40 3.70 4.15 3.27 3.47 3.86 4.12 4.59 5.08 5.29 5.48 14.45 14.86 14.859
DSO 48 49 51 51 51 49 53 51 50 48 54 53 50 48 48 46 44 42 41 39 38.5 days
DIO 206 210 233 229 237 228 269 257 236 210 225 213 191 179 226 204 196 189 238 232 231.8 days
DPO 100 102 84 82 85 82 113 107 99 88 112 105 94 89 80 72 69 67 25 25 24.6 days
Cash Conversion Cycle 154 157 200 198 203 194 210 200 187 171 168 160 146 138 195 179 171 165 254 246 245.7 days
Fixed Asset Turnover snapshot only 2.519
Operating Cycle snapshot only 270.3 days
Cash Velocity snapshot only 6.698
Capital Intensity snapshot only 0.931
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 26.6% 18.8% 13.4% 6.9% -1.8% 4.4% 8.8% 13.3% 15.4% 13.7% 14.7% 13.5% 17.3% 18.8% 17.8% 18.8% 17.2% 18.7% 20.2% 22.4% 22.41%
Net Income 23.7% -11.7% -13.4% -42.9% -43.5% -4.0% -7.3% 22.8% 25.8% 19.4% 25.0% 13.3% 29.5% 38.4% 54.1% 66.3% 71.8% 85.3% -57.6% -3.4% -3.39%
EPS 26.1% -8.0% -10.1% -39.1% -40.4% -2.2% -5.1% 24.2% 27.3% 20.9% 26.3% 14.6% 30.9% 39.6% 58.9% 67.8% 73.0% 86.0% -61.4% -2.8% -2.85%
FCF 28.5% 7.9% -34.5% -37.1% -72.0% -21.9% 15.4% 28.9% 42.4% 42.3% 44.3% 30.8% 42.9% 57.7% 1.0% 1.0% 1.3% 1.3% -299.0% 47.8% 47.81%
EBITDA 39.6% 0.8% -8.4% -54.1% -66.5% -11.6% -12.2% 25.4% 28.8% 25.8% 43.1% 48.6% 88.4% 1.1% 1.5% 1.9% 6.1% 11.5% 45.2% -35.2% -35.20%
Op. Income 34.7% -0.8% -9.6% -46.1% -58.1% -15.8% -16.9% 15.7% 21.0% 18.9% 27.8% 27.4% 50.6% 64.4% 84.7% 97.9% 1.1% 1.5% -1.4% -22.2% -22.25%
OCF Growth snapshot only 3.29%
Asset Growth snapshot only 8.82%
Equity Growth snapshot only 24.00%
Debt Growth snapshot only -71.99%
Shares Change snapshot only 14.13%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 22.6% 18.3% 14.9% 12.3% 10.1% 9.5% 9.1% 10.2% 12.8% 12.1% 12.3% 11.2% 9.9% 12.1% 13.7% 15.2% 16.6% 17.0% 17.6% 18.2% 18.18%
Revenue 5Y 30.5% 27.9% 25.4% 23.0% 20.7% 19.5% 18.1% 17.1% 15.9% 14.5% 13.6% 12.7% 12.5% 12.1% 11.9% 12.6% 14.5% 14.7% 14.9% 14.9% 14.87%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 21.4% 17.1% 13.7% 11.0% 9.3% 8.8% 8.6% 10.0% 13.1% 11.7% 11.3% 9.6% 7.6% 9.5% 10.8% 11.5% 12.6% 13.2% 13.5% 14.5% 14.52%
Gross Profit 5Y 30.1% 27.3% 24.7% 22.1% 20.1% 19.0% 17.5% 16.5% 15.0% 13.1% 12.0% 10.9% 10.5% 10.0% 9.7% 10.1% 12.6% 13.0% 13.0% 13.0% 12.95%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 50.7% 50.7% 9.1% 9.1% 9.1% 9.1% 8.1% 8.1% 8.1% 8.1% -0.8% -0.8% -0.8% -0.8% -0.7% -0.7% -0.7% -0.7% 4.3% 4.3% 4.30%
Assets 5Y 39.9% 39.9% 35.0% 35.0% 35.0% 35.0% 27.1% 27.1% 27.1% 27.1% 4.2% 4.2% 4.2% 4.2% 5.7% 5.7% 5.7% 5.7% 1.9% 1.9% 1.94%
Equity 3Y 69.7% 69.7% -8.5% -8.5% -8.5% -8.5% -8.6% -8.6% -8.6% -8.6% -8.1% -8.1% -8.1% -8.1% -2.6% -2.6% -2.6% -2.6% 8.5% 8.5% 8.46%
Book Value 3Y 63.4% 65.6% -10.6% -10.7% -10.6% -10.6% -10.7% -10.7% -10.8% -10.7% -10.1% -9.9% -10.0% -9.8% -7.3% -5.1% -5.3% -5.3% 4.8% 1.7% 1.73%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.99 0.98 0.97 0.96 0.94 0.95 0.96 0.97 0.95 0.99 0.99 0.99 0.93 0.94 0.94 0.94 0.96 0.95 0.95 0.92 0.924
Earnings Stability 0.66 0.86 0.64 0.67 0.69 0.78 0.59 0.34 0.18 0.16 0.00 0.12 0.29 0.47 0.55 0.52 0.65 0.69 0.54 0.03 0.034
Margin Stability 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.98 0.98 0.97 0.97 0.97 0.96 0.96 0.95 0.96 0.96 0.96 0.95 0.952
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Earnings Persistence 0.91 0.95 0.95 0.83 0.83 0.98 0.97 0.91 0.90 0.92 0.90 0.95 0.88 0.85 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.02 -0.04 -0.03 -0.09 -0.08 -0.05 -0.07 -0.01 -0.00 0.01 0.04 0.04 0.08 0.09 0.16 0.16 0.16 0.17 0.04 -0.10 -0.098
Gross Margin Trend -0.00 -0.00 -0.00 -0.01 0.01 0.01 0.01 0.01 -0.01 -0.03 -0.04 -0.04 -0.05 -0.05 -0.05 -0.06 -0.05 -0.03 -0.03 -0.01 -0.011
FCF Margin Trend 0.13 0.03 -0.08 -0.08 -0.07 -0.01 0.05 0.09 0.10 0.13 0.17 0.15 0.18 0.17 0.19 0.18 0.15 0.12 0.05 0.10 0.104
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.27 0.33 0.50 0.43 0.59 0.66 0.55 0.51 0.28 0.18 0.26 0.50 0.40 0.31 -0.46 -0.51 -1.54 -3.10 -0.05 -0.49 -0.495
FCF/OCF 4.36 3.67 3.19 3.28 2.44 2.14 2.25 2.56 4.05 5.65 3.52 2.08 2.23 2.24 0.00 0.05 0.59 0.44 -4.04 0.57 0.574
FCF/Net Income snapshot only -0.284
OCF/EBITDA snapshot only 2.732
CapEx/Revenue 15.6% 18.8% 23.0% 24.4% 20.9% 16.1% 14.5% 13.4% 13.3% 12.6% 9.1% 7.0% 4.8% 3.0% 2.4% 1.8% 1.4% 1.7% 1.8% 2.8% 2.78%
CapEx/Depreciation snapshot only 1.021
Accruals Ratio -0.09 -0.10 -0.07 -0.09 -0.06 -0.05 -0.06 -0.06 -0.08 -0.09 -0.08 -0.05 -0.05 -0.05 -0.07 -0.05 -0.06 -0.04 -0.08 -0.22 -0.221
Sloan Accruals snapshot only 0.102
Cash Flow Adequacy snapshot only 2.349
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.5% -0.6% -0.3% -0.3% -0.5% -0.4% -0.4% -0.6% -0.7% -1.1% -0.7% -0.4% -0.4% -0.2% -0.2% -0.5% -0.9% -0.6% -0.5% -8.4% -8.38%
Total Shareholder Return -0.5% -0.6% -0.3% -0.3% -0.5% -0.4% -0.4% -0.6% -0.7% -1.1% -0.7% -0.4% -0.4% -0.2% -0.2% -0.5% -0.9% -0.6% -0.5% -8.4% -8.38%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.10 1.08 1.05 1.04 1.03 1.02 1.02 1.01 1.01 1.04 1.15 1.32 1.77 2.36 5.66 -7.42 -1.43 -0.15 -34.66 39.56 39.564
EBIT Margin -0.15 -0.20 -0.20 -0.24 -0.24 -0.21 -0.20 -0.17 -0.16 -0.15 -0.12 -0.10 -0.05 -0.03 -0.01 0.00 0.02 0.07 0.00 -0.00 -0.003
Asset Turnover 0.73 0.72 0.62 0.62 0.63 0.65 0.69 0.72 0.73 0.75 0.81 0.83 0.88 0.92 0.94 0.97 1.01 1.07 1.06 1.12 1.119
Equity Multiplier 1.39 1.39 1.74 1.74 1.74 1.74 1.89 1.89 1.89 1.89 1.99 1.99 1.99 1.99 2.01 2.01 2.01 2.01 1.83 1.83 1.828
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.54 $-0.67 $-0.65 $-0.76 $-0.75 $-0.68 $-0.68 $-0.58 $-0.55 $-0.54 $-0.50 $-0.49 $-0.38 $-0.33 $-0.21 $-0.16 $-0.10 $-0.05 $-0.33 $-0.61 $-0.61
Book Value/Share $3.00 $2.97 $2.71 $2.69 $2.68 $2.67 $2.39 $2.37 $2.36 $2.35 $2.22 $2.21 $2.19 $2.18 $2.16 $2.30 $2.28 $2.26 $2.75 $2.50 $4.75
Tangible Book/Share $2.95 $2.92 $2.65 $2.62 $2.61 $2.60 $2.30 $2.29 $2.27 $2.26 $2.12 $2.11 $2.08 $2.08 $2.05 $2.18 $2.16 $2.14 $2.60 $2.37 $2.37
Revenue/Share $3.18 $3.09 $3.07 $3.05 $3.05 $3.17 $3.28 $3.39 $3.45 $3.54 $3.69 $3.79 $3.97 $4.12 $3.90 $4.30 $4.46 $4.68 $4.80 $4.62 $4.62
FCF/Share $-0.64 $-0.80 $-1.03 $-1.07 $-1.08 $-0.96 $-0.85 $-0.75 $-0.61 $-0.54 $-0.47 $-0.51 $-0.34 $-0.23 $0.00 $0.00 $0.09 $0.06 $-0.07 $0.17 $0.17
OCF/Share $-0.15 $-0.22 $-0.32 $-0.33 $-0.44 $-0.45 $-0.38 $-0.29 $-0.15 $-0.10 $-0.13 $-0.24 $-0.15 $-0.10 $0.09 $0.08 $0.16 $0.14 $0.02 $0.30 $0.30
Cash/Share $2.53 $2.51 $2.03 $2.01 $2.00 $1.99 $1.15 $1.15 $1.14 $1.13 $0.72 $0.72 $0.71 $0.71 $0.70 $0.74 $0.73 $0.73 $0.76 $0.69 $1.60
EBITDA/Share $-0.38 $-0.51 $-0.50 $-0.62 $-0.62 $-0.55 $-0.55 $-0.45 $-0.43 $-0.40 $-0.31 $-0.23 $-0.05 $0.04 $0.13 $0.19 $0.24 $0.47 $0.19 $0.11 $0.11
Debt/Share $1.33 $1.32 $1.63 $1.61 $1.61 $1.60 $1.59 $1.58 $1.57 $1.57 $1.61 $1.60 $1.59 $1.58 $1.43 $1.52 $1.51 $1.50 $0.41 $0.37 $0.37
Net Debt/Share $-1.20 $-1.19 $-0.40 $-0.40 $-0.40 $-0.39 $0.44 $0.44 $0.43 $0.43 $0.89 $0.89 $0.88 $0.87 $0.73 $0.78 $0.77 $0.77 $-0.35 $-0.32 $-0.32
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 10.694
Altman Z-Prime snapshot only 17.659
Piotroski F-Score 5 5 3 3 3 4 3 3 3 3 4 4 4 4 6 6 7 7 6 6 6
Beneish M-Score -2.60 -2.80 -2.59 -2.73 -2.62 -2.49 -2.47 -2.42 -2.53 -2.56 -2.59 -2.48 -2.41 -2.46 -2.70 -2.58 -2.67 -2.60 -2.68 -3.33 -3.330
Ohlson O-Score snapshot only -6.584
ROIC (Greenblatt) snapshot only -0.42%
Net-Net WC snapshot only $0.53
EVA snapshot only $-18379900.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A-
Credit Score 58.73 58.69 37.06 38.02 38.60 44.74 40.35 39.99 40.07 35.50 35.53 35.15 35.34 40.73 54.06 57.06 43.74 60.26 65.52 68.00 67.999
Credit Grade snapshot only 7
Credit Trend snapshot only 10.935
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 64
Sector Credit Rank snapshot only 64

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms